%0 Journal Article %T Noninfectious Complications in B-Lymphopenic Common Variable Immunodeficiency. %A Pashangzadeh S %A Delavari S %A Moeini Shad T %A Salami F %A Rasouli SE %A Yazdani R %A Mahdaviani SA %A Nabavi M %A Aleyasin S %A Ahanchian H %A Jabbari-Azad F %A Chavoshzadeh Z %A Nazari F %A Momen T %A Sherkat R %A Abolnezhadian F %A Esmaeilzadeh H %A Fallahpour M %A Arshi S %A Bemanian MH %A Shokri S %A Ebrahimi SS %A Abolmolouki M %A Farid AS %A Rezaei A %A Esmaeili M %A Kalantari A %A Sadeghi-Shabestari M %A Shirkani A %A Behniafard N %A Khalili A %A Eslamian MH %A Cheraghi T %A Shafie A %A Tavakol M %A Khoshkhui M %A Iranparast S %A Shamshiri M %A Shahri MA %A Khazaei R %A Asadi M %A Babaha F %A Aghamohammadi A %A Rezaei N %A Abolhassani H %J J Investig Allergol Clin Immunol %V 34 %N 4 %D 2024 Jul %M 39077769 %F 8.185 %R 10.18176/jiaci.0902 %X BACKGROUND: Common variable immunodeficiency (CVID) is considered the most symptomatic type of inborn errors of immunity in humans. Along with infectious complications, which have numerous consequences, noninfectious complications are a major challenge among CVID patients.
METHODS: All CVID patients registered in the national database were included in this retrospective cohort study. Patients were divided into 2 groups based on the presence of B-cell lymphopenia. Demographic characteristics, laboratory findings, noninfectious organ involvement, autoimmunity, and lymphoproliferative diseases were evaluated.
RESULTS: Among 387 enrolled patients, 66.4% were diagnosed with noninfectious complications and 33.6% with isolated infectious presentations. Enteropathy, autoimmunity, and lymphoproliferative disorders were reported in 35.1%, 24.3%, and 21.4% of patients, respectively. Some complications, including autoimmunity and hepatosplenomegaly, were reported to be significantly more frequent among patients with B-cell lymphopenia. As for organ involvement, the dermatologic, endocrine, and musculoskeletal systems were predominantly affected in CVID patients with B-cell lymphopenia. Among autoimmune manifestations, the frequency of rheumatologic, hematologic, and gastrointestinal autoimmunity was reported to be higher than that of other types of autoimmunity not associated with B cell-lymphopenia. Furthermore, hematological cancers, particularly lymphoma, were the most common type of malignancy. The mortality rate was 24.5%, and respiratory failure and malignancies were the most common causes of death, with no significant differences between the 2 groups.
CONCLUSIONS: Considering that some of the noninfectious complications might be associated with B-cell lymphopenia, regular patient monitoring and follow-up with proper medication (in addition to immunoglobulin replacement therapy) are highly recommended to prevent sequelae and increase patient quality of life.